THY1 and chronic kidney disease: Therefore, this study in chronic anti-thy1 mesangioproliferative glomerulosclerosis proved that the inhibition of tyrosine kinases signalling through Imatinib directly or indirectly interferes with multiple key pathways to slow the progression of chronic renal disease.